TRIO Pharmaceuticals
TRIO Pharmaceuticals is a biotechnology company developing bispecific antibodies for cancer treatment. Their proprietary TRAILBody™ and TIE-ADC™ platforms combine targeted tumor growth inhibition with immune system modulation for potent, less toxic therapies. This approach addresses high unmet medical needs in cancers like multiple myeloma and leukemia.
Buy Funded Startups lists
Funding Round: Pre-Series A
Funding Amount: $3.1M
Date: 03-Dec-2024
Investors: Friedman Bioventure Fund (FBVF), Multiple Myeloma Research Foundation (MMRF) through its Myeloma Investment Fund (MIF), NuFund Venture Group, Life Science Angels
Markets: Biotechnology, Cancer Therapeutics, Immunotherapy, Health Care, Medical, Therapeutics, Drug Discovery, Life Sciences, Oncology
HQ: San Diego, California, United States
Founded: 2018
Website: https://www.triopharmaceuticals.com/
LinkedIn: https://www.linkedin.com/company/trio-pharmaceutials-inc
Crunchbase: https://www.crunchbase.com/organization/trio-pharmaceuticals-inc
Leave a Comment
Comments
No comments yet.